Trial Profile

A phase I clinical trial to evaluate the safety and early efficacy of the combination therapy (SSTN-302 and SST-1034) in patients with esophageal and gastrointestinal cancers

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 24 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Nov 2025 New trial record
28 Oct 2025 According to a DeGregorio Family Foundation media release, the Foundation with support from the Esophageal Cancer Awareness Association, has awarded an additional $75,000 to support launch a phase I clinical trial. This initial funding is described as essential for beginning the process of establishing the trial, which potentially to be conducted at the University of Miami's Sylvester Comprehensive Cancer Center.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com